References of "Penning, Sophie"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailInterface Design and Human Factors Consideration for Model-Based Tight Glycemic Control in Critical Care
Ward, Logan; Steel, James; Le Compte, Aaron et al

in Journal of Diabetes Science and Technology (2012)

Detailed reference viewed: 10 (2 ULg)
Full Text
Peer Reviewed
See detailStochastic Targeted (STAR) Glycemic Control - Design, Safety and Performance
Evans, Alicia; Le Compte, Aaron; Tan, Chian-Siong et al

in Journal of Diabetes Science and Technology (2012)

Detailed reference viewed: 13 (3 ULg)
Full Text
Peer Reviewed
See detailData Entry Errors and Design for Model-Based Tight Glycemic Control in Critical Care
Ward, Logan; Steel, James; Le Compte, Aaron et al

in Journal of Diabetes Science and Technology (2012)

Detailed reference viewed: 10 (8 ULg)
Full Text
Peer Reviewed
See detailGlycemic Variability, Hypoglycemia and Organ Failure in the Glucontrol Study
Penning, Sophie ULg; Le Compte, Aaron J.; Preiser, Jean-Charles et al

Poster (2011, December)

Detailed reference viewed: 17 (7 ULg)
Full Text
Peer Reviewed
See detailEnhanced insulin sensitivity variability in the first 3 days of ICU stay: Implications for TGC
Chase, J. Geoffrey; Le Compte, Aaron; Penning, Sophie ULg et al

in Critical Care (2011, March)

Detailed reference viewed: 11 (7 ULg)
Full Text
Peer Reviewed
See detailValidation of a virtual patient and virtual trials method for accurate prediction of TGC protocol performance
Suhaimi, Fatanah; Le Compte, Aaron; Penning, Sophie ULg et al

in Critical Care (2011, March)

Detailed reference viewed: 16 (8 ULg)
Full Text
Peer Reviewed
See detailValidation of a Virtual Patient and Virtual Trials Method for Accurate Prediction of TGC Protocol Performance
Suhaimi, Fatanah; Le Compte, Aaron; Penning, Sophie ULg et al

Poster (2011, March)

Detailed reference viewed: 18 (7 ULg)
Full Text
Peer Reviewed
See detailEnhanced insulin sensitivity variability in the first 3 days of ICU stay: Implications for TGC
Chase, Geoffrey; Le Compte, Aaron; Penning, Sophie ULg et al

Poster (2011, March)

Detailed reference viewed: 19 (7 ULg)
Full Text
Peer Reviewed
See detailInsulin Sensitivity, Its Variability and Glycemic Outcome: A model-based analysis of the difficulty in achieving tight glycemic control in critical care
Chase, J. Geoffrey; Le Compte, Aaron J.; Preiser, Jean-Charles et al

in 18th World Congress of the International Federation of Automatic Control (IFAC) (2011)

Effective tight glycemic control (TGC) can improve outcomes in intensive care unit (ICU) <br />patients, but is difficult to achieve consistently. Glycemic level and variability, particularly early in a ... [more ▼]

Effective tight glycemic control (TGC) can improve outcomes in intensive care unit (ICU) <br />patients, but is difficult to achieve consistently. Glycemic level and variability, particularly early in a <br />patient’s stay, are a function of variability in insulin sensitivity/resistance resulting from the level and <br />evolution of stress response, and are independently associated with mortality. This study examines the <br />daily evolution of variability of insulin sensitivity in ICU patients using patient data (N = 394 patients, <br />54019 hours) from the SPRINT TGC study. Model-based insulin sensitivity (SI) was identified each hour <br />and hour-to-hour percent changes in SI were assessed for Days 1-3 individually and Day 4 Onward, as <br />well as over all days. Cumulative distribution functions (CDFs), median values, and inter-quartile points <br />(25th and 75th percentiles) are used to assess differences between groups and their evolution over time. <br />Compared to the overall (all days) distributions, ICU patients are more variable on Days 1 and 2 (p < <br />0.0001), and less variable on Days 4 Onward (p < 0.0001). Day 3 is similar to the overall cohort (p = 0.74). <br />Absolute values of SI start lower and rise for Days 1 and 2, compared to the overall cohort (all days), (p < <br />0.0001), are similar on Day 3 (p = .72) and are higher on Days 4 Onward (p < 0.0001). ICU patients have <br />lower insulin sensitivity (greater insulin resistance) and it is more variable on Days 1 and 2, compared to <br />an overall cohort on all days. This is the first such model-based analysis of its kind. Greater variability <br />with lower SI early in a patient’s stay greatly increases the difficulty in achieving and safely maintaining <br />glycemic control, reducing potential positive outcomes. Clinically, the results imply that TGC patients will <br />require greater measurement frequency, reduced reliance on insulin, and more explicit specification of <br />carbohydrate nutrition in Days 1-3 to safely minimise glycemic variability for best outcome. [less ▲]

Detailed reference viewed: 21 (10 ULg)
Full Text
Peer Reviewed
See detailSafety and Performance of Stochastic Targeted (STAR) TGC of Insulin and Nutrition
Shaw, GM; Le Compte, Aaron; Evans, A et al

in Proceedings of SQAO 2011 (2011)

Detailed reference viewed: 12 (0 ULg)
Full Text
Peer Reviewed
See detailPilot Trials of STAR Target to Range Glycemic Control
Penning, Sophie ULg; Le Compte, Aaron; Massion, Paul et al

in Intensive Care Medicine (2011), 37 (Suppl 1)

Detailed reference viewed: 13 (5 ULg)
Full Text
Peer Reviewed
See detailVariability of insulin sensitivity for diabetics and non-diabetics during the first 3 days of ICU stay
Pretty, Christopher G.; Le Compte, Aaron; Preiser, Jean-Charles et al

in Intensive Care Medicine (2011), 37 (Suppl 1)

Detailed reference viewed: 9 (3 ULg)
Peer Reviewed
See detailVariability of insulin sensitivity for diabetics and non-diabetics during the first 3 days of ICU stay
Pretty, Christopher G.; Le Compte, Aaron; Preiser, Jean-Charles et al

Poster (2011)

Detailed reference viewed: 7 (2 ULg)
Peer Reviewed
See detailSafety and Performance of Stochastic Targeted (STAR) Glycemic Control of Insulin and Nutrition - First Pilot Results
Shaw, Geoffrey M.; Le Compte, Aaron; Evans, Alicia et al

Poster (2011)

Detailed reference viewed: 6 (2 ULg)
Full Text
Peer Reviewed
See detailSafety and Performance of Stochastic Targeted (STAR) Glycemic Control of Insulin and Nutrition – First Pilot Results
Shaw, Geoffrey M.; Le Compte, Aaron; Evans, Alicia et al

in Intensive Care Medicine (2011)

Detailed reference viewed: 9 (2 ULg)
Full Text
Peer Reviewed
See detailPilot Trials of STAR Target to Range Glycemic Control
Penning, Sophie ULg; Le Compte, Aaron; Massion, Paul et al

Poster (2011)

Detailed reference viewed: 8 (2 ULg)
Full Text
Peer Reviewed
See detailGlycemic Variability, Hypoglycemia and Organ Failure in the Glucontrol Study
Penning, Sophie ULg; Le Compte, Aaron J.; Preiser, Jean-Charles et al

in 10th Belgian Day on Biomedical Engineering (2011)

Detailed reference viewed: 13 (3 ULg)
Full Text
Peer Reviewed
See detailTight Glycemic Control in Intensive Care: From engineering to clinical practice change
Chase, J. G.; Le Compte, A. J.; Evans, A. et al

in 5th European Conference of the International Federation for Medical and Biological Engineering (2011)

Tight glycemic control (TGC) is prevalent in critical care. Providing safe, effective TGC has proven very difficult to achieve with clinically derived protocols. The prob-lem is exacerbated by extreme ... [more ▼]

Tight glycemic control (TGC) is prevalent in critical care. Providing safe, effective TGC has proven very difficult to achieve with clinically derived protocols. The prob-lem is exacerbated by extreme patient variability and the need to minimize clinical effort and burden. These ingredients make an ideal scenario for model-based methods to provide opti-mised solutions. This paper presents the development, clinical-ly validated virtual trials optimisation, and initial clinical implementation of a stochastic targeted (STAR) TGC method and framework. It is compared to a prior successful, model-derived, less flexible and dynamic TGC protocol (SPRINT). The use of stochastic models to safely forecast a range of glu-cose outcomes over 1-3 hours ensures better performance, more dynamic use of the range of insulin and nutrition inputs and thus better glycemic performance and safety from hypo-glycemia, the latter of which was reduced by 3.0x times. Hence, the paper presents an overall engineering approach to TGC from engineering models to clinical implementation and ongo-ing clinical practice change. [less ▲]

Detailed reference viewed: 18 (4 ULg)